Cite
HARVARD Citation
Othus, M. et al. (2023). Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Leukemia & lymphoma. 64 (1), pp. 250-252. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Othus, M. et al. (2023). Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Leukemia & lymphoma. 64 (1), pp. 250-252. [Online].